SARS-CoV-2 Omicron Spike Proteins & Antibodies
‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
View as a Web Page
 
Facebook Twitter Vimeo
News Medical
Clinical and Lab Diagnostics Newsletter
The latest clinical and lab diagnostics news from News Medical

A selection of the leading Clinical and Lab Diagnostics articles for 2021...

SARS-CoV-2 Omicron Spike Proteins & Antibodies

The Omicron strain is by far the most divergent SARS-CoV-2 variant. It is critical to re-evaluate the effectiveness of the current diagnostics and therapeutics against this new variant. Sino Biological has developed recombinant Omicron Spike and Nucleocapsid proteins and validated all available antibodies against the Omicron proteins.

Browse the range

Using Flow Cytometry in Disease Diagnosis

Flow cytometry is a robust analytical technique that has rapidly become one of the standard analytical techniques used in medical research.

Read More
 

What is a Diagnosis?

Diagnosis in healthcare is among the most important processes since the protocol for patient treatment depends on this step. Even more, health research and policy draw on this area for their validity.

Read More
A selection of the leading Clinical and Lab Diagnostics news stories for 2021...

SARS-CoV-2 Variant Reagent Bank

Several new variants of SARS-CoV-2 virus have emerged, especially the most recent Omicron is particularly concerning because of the high prevalence. Sino Biological has developed a panel of recombinant RBD/Spike and nucleocapsid protein variants which can be used to evaluate the efficacy of the antibodies and vaccination.

Browse the reagent bank

Blood group associated with cardiovascular events in COVID-19 patients

An illuminating new study by scientists at Harvard Medical School, USA, describes the correlation of such conditions with the ABO blood group. The team's findings may help assess the risk of COVID-19 patients for such complications, promoting early diagnosis and underscoring potential needs for preventive and therapeutic care where possible.

Read More
 

Taste loss as a COVID-19 symptom: a review

A new review reports that alterations in taste affected about a third of individuals with a COVID-19 diagnosis, with females being affected more than males. While not dangerous, the affected individuals may find it distressing. The symptoms typically resolve within weeks to months. By six months, the majority of patients report that they have regained normal sensation.

Read More
More Clinical and Lab Diagnostics stories from 2021...

New Recombinant Cytokines & Research Reagents

Sino Biological has recently announced a number of new reagents, including recombinant premium cytokines, therapeutic targets for neurodegenerative diseases, and newly launched SARS-CoV-2 research reagents. Download this free guide to learn more.

Download the free guide

An Overview of ELISA

Enzyme-Linked Immunosorbent Assay (ELISA) is an immunological assay that is used to detect and quantify substances such as antibodies in liquid samples. The antibody is the central component of the performance of an ELISA, providing the basis of analyte selection and detection.

Read More
 

The role of nanotechnology in the fight against COVID-19

Appearing in the journal Nanomedicine, the review summarized all the exciting advances made using diverse nanomaterials (polymeric, inorganic self-assembling materials and peptide-based) towards COVID-19 prevention, diagnosis and therapy.

Read More
AZoNetwork UK Ltd.
NEO, 9 Charlotte St, Manchester, M1 4ET, UK
44 (0)161 457 7150

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not Interested Anymore?
Unsubscribe or Update your Notification Preferences

Copyright © 2000-2024